Healthcare stocks were slightly higher Monday with the NYSE Healthcare Sector Index climbing 0.2% and shares of healthcare companies in the S&P 500 rising 0.1% as a group.
In company news, Acasti Pharma (ACST,APO.V) was on track to finish Monday trade with another decline, with shares down over 4% shortly before the closing bell after the drugmaker said it chief financial officer has left the company.
The company said Xavier Harland's resignation was effective immediately. He will be replaced by Andre Godin, who also is the CFO at Neptune Technologies and Bioresources ( NEPT ).
ACST shares recently were down 4.1% at 95 cents each, earlier sinking to a session low of 89 cents a share. The stock has a 52-week range of 80 cents to $68.89 a share, sinking slightly more than 64% over the past 12 months.
APO.V shares were down 5.6% at C$1.01 each on Canada's Vancouver Venture exchange. NEPT was off 3.2% at $2.46 a share.
In other sector news,
(+) BLUE, Reports positive results for its LentiGlobin experimental gene therapy, saying two patients with the beta-thalassemia blood disorder were able to stop blood transfusions after one LentiGlobin treatment.
(-) KPTI, FDA Center for Veterinary Medicine offers only conditional support for the company's Verdinexor drug candidate to treat canine lymphoma.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.